Claudia Lanari

3.0k total citations
98 papers, 2.4k citations indexed

About

Claudia Lanari is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Claudia Lanari has authored 98 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Genetics, 55 papers in Oncology and 39 papers in Molecular Biology. Recurrent topics in Claudia Lanari's work include Estrogen and related hormone effects (58 papers), Cancer Cells and Metastasis (25 papers) and Cytokine Signaling Pathways and Interactions (17 papers). Claudia Lanari is often cited by papers focused on Estrogen and related hormone effects (58 papers), Cancer Cells and Metastasis (25 papers) and Cytokine Signaling Pathways and Interactions (17 papers). Claudia Lanari collaborates with scholars based in Argentina, United States and Portugal. Claudia Lanari's co-authors include Alfredo Molinolo, Caroline A. Lamb, Sebastián Giulianelli, Christiane Dosne Pasqualini, Victoria Fabris, Silvia I. Vanzulli, Victoria Wargon, Luísa A. Helguero, Isabel A Lüthy and Virginia Novaro and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Claudia Lanari

97 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Lanari Argentina 29 1.1k 1.0k 966 436 295 98 2.4k
Andrea R. Daniel United States 23 719 0.7× 714 0.7× 750 0.8× 284 0.7× 261 0.9× 44 1.8k
Yoko Omoto Japan 29 870 0.8× 1.2k 1.1× 1.1k 1.2× 553 1.3× 195 0.7× 49 2.5k
Oliver Treeck Germany 25 543 0.5× 732 0.7× 734 0.8× 340 0.8× 181 0.6× 87 1.7k
Yolande Berthois France 21 737 0.7× 1.2k 1.1× 1.2k 1.3× 366 0.8× 236 0.8× 54 2.5k
Raphael C. Guzman United States 25 1.2k 1.1× 822 0.8× 1.3k 1.3× 432 1.0× 173 0.6× 49 2.6k
Martine Perrot‐Applanat France 25 387 0.4× 613 0.6× 926 1.0× 308 0.7× 366 1.2× 33 1.9k
Yoshikazu Masuhiro Japan 19 803 0.7× 1.7k 1.6× 1.7k 1.7× 266 0.6× 293 1.0× 28 3.1k
Andrea Sacchetti Netherlands 25 821 0.8× 317 0.3× 1.2k 1.2× 401 0.9× 249 0.8× 50 2.4k
Dany Chalbos France 34 991 0.9× 1.2k 1.2× 1.7k 1.8× 815 1.9× 460 1.6× 58 3.0k
Xuesen Dong Canada 32 435 0.4× 373 0.4× 1.7k 1.8× 682 1.6× 306 1.0× 80 2.9k

Countries citing papers authored by Claudia Lanari

Since Specialization
Citations

This map shows the geographic impact of Claudia Lanari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Lanari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Lanari more than expected).

Fields of papers citing papers by Claudia Lanari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Lanari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Lanari. The network helps show where Claudia Lanari may publish in the future.

Co-authorship network of co-authors of Claudia Lanari

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Lanari. A scholar is included among the top collaborators of Claudia Lanari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Lanari. Claudia Lanari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enrico, Diego, et al.. (2024). Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6. Scientific Reports. 14(1). 25136–25136. 1 indexed citations
2.
Lamb, Caroline A., Isabel A Lüthy, Federico J. Díez, et al.. (2023). Steroid profile in patients with breast cancer and in mice treated with mifepristone. Endocrine Related Cancer. 31(2). 2 indexed citations
3.
Giulianelli, Sebastián, Caroline A. Lamb, & Claudia Lanari. (2021). Progesterone receptors in normal breast development and breast cancer. Conicet. 8 indexed citations
4.
Kordon, Edith C., et al.. (2021). The BA-BCS 2021: An Initial “Trial” for Integrating Basic Science and Medical Progress on Breast Cancer in a Latin-American Country. Journal of Mammary Gland Biology and Neoplasia. 26(3). 227–234. 2 indexed citations
5.
Dalotto‐Moreno, Tomás, Silvia I. Vanzulli, Derek C. Radisky, et al.. (2020). Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity. Cancer Research. 81(5). 1375–1387. 25 indexed citations
6.
May, María, Sabrina Copsel, Caroline A. Lamb, et al.. (2017). A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 22(1). 43–57. 15 indexed citations
7.
Giulianelli, Sebastián, José P. Vaqué, Rocío Soldati, et al.. (2012). Estrogen Receptor Alpha Mediates Progestin-Induced Mammary Tumor Growth by Interacting with Progesterone Receptors at the Cyclin D1/MYC Promoters. Cancer Research. 72(9). 2416–2427. 79 indexed citations
8.
Lanari, Claudia, Victoria Wargon, Paola Rojas, & Alfredo A. Molinolo. (2012). Antiprogestins in breast cancer treatment: are we ready?. Endocrine Related Cancer. 19(3). R35–R50. 68 indexed citations
9.
Fabris, Victoria, et al.. (2012). Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I. Cancer Genetics. 205(4). 168–176. 16 indexed citations
10.
Cerliani, Juan P., Sebastián Giulianelli, José P. Vaqué, et al.. (2011). Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer. Cancer Research. 71(10). 3720–3731. 69 indexed citations
11.
Riggio, Marina, Matı́as Blaustein, Alejandro Colman‐Lerner, et al.. (2011). PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer. Carcinogenesis. 33(3). 509–518. 39 indexed citations
12.
Fabris, Victoria, Silvia I. Vanzulli, Lucas L. Colombo, et al.. (2010). Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth. BMC Cancer. 10(1). 293–293. 13 indexed citations
13.
Arruvito, Lourdes, Sebastián Giulianelli, Ana Claudia Flores, et al.. (2008). NK Cells Expressing a Progesterone Receptor Are Susceptible to Progesterone-Induced Apoptosis. The Journal of Immunology. 180(8). 5746–5753. 132 indexed citations
14.
Efeyan, Alejo, et al.. (2004). Establishment of Two Hormone-responsive Mouse Mammary Carcinoma Cell Lines Derived from a Metastatic Mammary Tumor. Breast Cancer Research and Treatment. 83(3). 233–244. 10 indexed citations
15.
Lanari, Claudia & Alfredo Molinolo. (2003). Progestágenos y cáncer de mama: desarrollo de un modelo experimental. 2(3). 111–121. 1 indexed citations
16.
Helguero, Luísa A., et al.. (2003). Progesterone Receptor Expression in Medroxyprogesterone Acetate-Induced Murine Mammary Carcinomas and Response to Endocrine Treatment. Breast Cancer Research and Treatment. 79(3). 379–390. 31 indexed citations
17.
Vermeulen, Mónica, Patricia Pazos, Claudia Lanari, et al.. (2001). Medroxyprogesterone acetate enhances in vivo and in vitro antibody production. Immunology. 104(1). 80–86. 23 indexed citations
18.
Elizalde, Patricia V., Claudia Lanari, Alfredo Molinolo, et al.. (1998). Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas. The Journal of Steroid Biochemistry and Molecular Biology. 67(4). 305–317. 18 indexed citations
19.
Lanari, Claudia, et al.. (1997). [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].. PubMed. 57 Suppl 2. 55–69. 8 indexed citations
20.
Kordon, Edith C., Alfredo Molinolo, Patricia V. Elizalde, et al.. (1994). Effect of sialoadenectomy on medroxyprogesterone‐acetate‐induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal‐growth‐factor receptor content. International Journal of Cancer. 59(2). 196–203. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea R. Daniel Breakdown of academic impact, for papers by Yoko Omoto Breakdown of academic impact, for papers by Oliver Treeck Breakdown of academic impact, for papers by Yolande Berthois Breakdown of academic impact, for papers by Raphael C. Guzman Breakdown of academic impact, for papers by Martine Perrot‐Applanat Breakdown of academic impact, for papers by Yoshikazu Masuhiro Breakdown of academic impact, for papers by Andrea Sacchetti Breakdown of academic impact, for papers by Dany Chalbos Breakdown of academic impact, for papers by Xuesen Dong
Rankless by CCL
2026